Evidence-Based Recommendations for Education Provided to Patients and Families Regarding the Adverse Events of ALK and MEK Inhibitors: A Systematic Review From the Children's Oncology Group

Conclusions: Adverse events of ALK and MEK inhibitors differ from the more common adverse events experienced with conventional treatment modalities used in pediatric oncology. It is important for nurses to include information regarding potential adverse events in patient/family education for children receiving these targeted agents.PMID:38549368 | DOI:10.1177/27527530231206101

Source: Ann Oncol - March 29, 2024 Category: Cancer & Oncology Authors: Beth Fisher Ashley Meyer Anastasia Brown Mary Conway Keller Tara McKeown Jennifer Tiller Kate M Saylor Elizabeth A Duffy Source Type: research